What is Fluxergy?
Fluxergy is at the forefront of developing a revolutionary platform equipped with multi-modal detection technologies. This innovative system aims to consolidate a wide array of tests traditionally performed in central laboratories into a portable, handheld device. The platform's capabilities span molecular testing, including PCR, immunochemistry, and chemistry analyses, alongside microscopy techniques such as cytometry. Fluxergy's overarching vision is to enable the simultaneous detection of genes, proteins, small molecules, and cells using a single analyzer, thereby streamlining complex diagnostic workflows.
How much funding has Fluxergy raised?
Fluxergy has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
What's next for Fluxergy?
With its large-scale, late-stage funding context, Fluxergy is poised for significant expansion and market penetration. The recent strategic investment signals strong confidence from stakeholders in the company's technology and its commercial viability. This capital infusion will likely fuel further research and development, scale manufacturing operations, and support broader market adoption of its diagnostic platform. The company's focus on integrating diverse testing modalities into a single, user-friendly device positions it to capture a substantial share of the rapidly growing point-of-care diagnostics market.
See full Fluxergy company page
